Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children. The MELA-PAED Trial: a Randomized, Double-blind, Placebo-controlled Trial.

NCT05541276 is registered in ClinicalTrials.gov with Arash Afshari as lead sponsor.

NCT NCT05541276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05541276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children. The MELA-PAED Trial: a Randomized, Double-blind, Placebo-controlled Trial.
Lead sponsor
Arash Afshari
Phase
Phase 3
Overall status
Recruiting
Start date
January 21, 2025
Completion date
April 1, 2027
Enrollment
676 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergence delirium